{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:01:46Z","timestamp":1791302506631,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010236"],"award-info":[{"award-number":["2023A1515010236"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2021-121"],"award-info":[{"award-number":["2021-121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023P-TS33"],"award-info":[{"award-number":["2023P-TS33"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372867"],"award-info":[{"award-number":["82372867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073162"],"award-info":[{"award-number":["82073162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.intimp.2024.112184","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T05:11:52Z","timestamp":1717218712000},"page":"112184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Integrated analysis of multiple transcriptomic approaches and machine learning integration algorithms reveals high endothelial venules as a prognostic immune-related biomarker in bladder cancer"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2914-8189","authenticated-orcid":false,"given":"Jinge","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranyang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenlan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112184_b0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskjot","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2024.112184_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.intimp.2024.112184_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100788","article-title":"Modulating undruggable targets to overcome cancer therapy resistance","volume":"60","author":"Passirani","year":"2022","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.intimp.2024.112184_b0020","doi-asserted-by":"crossref","DOI":"10.34133\/research.0211","article-title":"Supramolecular biomaterials for cancer immunotherapy","volume":"6","author":"Liang","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.intimp.2024.112184_b0025","article-title":"A novel therapeutic strategy for non-muscle invasive bladder cancer: OncoTherad\u00ae immunotherapy associated with platelet-rich plasma","volume":"123","author":"de Souza","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112184_b0030","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comperat","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112184_b0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2024.112184_b0040","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41423-020-0457-0","article-title":"Tertiary lymphoid structures in cancer - considerations for patient prognosis","volume":"17","author":"Munoz-Erazo","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.112184_b0045","doi-asserted-by":"crossref","first-page":"39-+","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.112184_b0050","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41581-023-00706-z","article-title":"The roles of tertiary lymphoid structures in chronic diseases","volume":"19","author":"Sato","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2024.112184_b0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ccell.2023.02.002","article-title":"High endothelial venules in cancer: regulation, function, and therapeutic implication","volume":"41","author":"Vella","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2024.112184_b0060","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.it.2022.07.002","article-title":"High endothelial venules as potential gateways for therapeutics","volume":"43","author":"Hussain","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2024.112184_b0065","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10456-021-09792-8","article-title":"High endothelial venules (HEVs) in immunity, inflammation and cancer","volume":"24","author":"Blanchard","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/j.intimp.2024.112184_b0070","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1158\/1078-0432.CCR-13-2590","article-title":"Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers","volume":"20","author":"Di Caro","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2024.112184_b0075","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4161\/onci.20492","article-title":"High endothelial venules (HEVs) in human melanoma lesions Major gateways for tumor-infiltrating lymphocytes","volume":"1","author":"Martinet","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2024.112184_b0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112184_b0085","doi-asserted-by":"crossref","first-page":"1350-+","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.112184_b0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.112184_b0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.112184_b0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.112184_b0105","doi-asserted-by":"crossref","first-page":"318-+","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2024.112184_b0110","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-11-0431","article-title":"Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer","volume":"71","author":"Martinet","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2024.112184_b0115","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2326-6066.CIR-21-0369","article-title":"Molecular signature of tumor-associated high endothelial venules that can predict breast cancer survival","volume":"10","author":"Sawada","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2024.112184_b0120","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003353","article-title":"High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer","volume":"9","author":"Park","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2024.112184_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082628","article-title":"High endothelial venule with concomitant high CD8+tumor-infiltrating lymphocytes is associated with a favorable prognosis in resected gastric cancer","volume":"9","author":"Hong","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2024.112184_b0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4143\/crt.2016.215","article-title":"Predictive value of tertiary lymphoid structures assessed by high endothelial venule counts in the neoadjuvant setting of triple-negative breast cancer","volume":"49","author":"Song","year":"2017","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.intimp.2024.112184_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153392","article-title":"High endothelial venules are present in pharyngeal and laryngeal carcinomas and they are associated with better prognosis","volume":"220","author":"Karpathiou","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.intimp.2024.112184_b0140","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.4049\/jimmunol.1300872","article-title":"High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin \u03b2-producing dendritic cells in human breast cancer","volume":"191","author":"Martinet","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112184_b0145","doi-asserted-by":"crossref","first-page":"1600-+","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1<SUP>+<\/SUP> T lymphocyte niches through a feed-forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2024.112184_b0150","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-01005-x","article-title":"RNA sequencing: new technologies and applications in cancer research","volume":"13","author":"Hong","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2024.112184_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41368-021-00146-0","article-title":"From bulk, single-cell to spatial RNA sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.intimp.2024.112184_b0160","article-title":"Data analysis guidelines for single-cell RNA-seq in biomedical studies and clinical applications","volume":"9","author":"Su","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.intimp.2024.112184_b0165","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: a brief overview","volume":"12","author":"Jovic","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.intimp.2024.112184_b0170","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-022-01075-1","article-title":"An introduction to spatial transcriptomics for biomedical research","volume":"14","author":"Williams","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.intimp.2024.112184_b0175","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-022-01448-2","article-title":"The expanding vistas of spatial transcriptomics","volume":"41","author":"Tian","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112184_b0180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","article-title":"Exploring tissue architecture using spatial transcriptomics","volume":"596","author":"Rao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112184_b0185","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-022-00879-y","article-title":"Spatial multi-omics analyses of the tumor immune microenvironment","volume":"29","author":"Hsieh","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2024.112184_b0190","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41576-023-00580-2","article-title":"Methods and applications for single-cell and spatial multi-omics","volume":"24","author":"Vandereyken","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.intimp.2024.112184_b0195","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.502","article-title":"Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancer","volume":"5","author":"Xie","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.intimp.2024.112184_b0200","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13513","article-title":"High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma","volume":"56","author":"Zhou","year":"2023","journal-title":"Cell Prolif."},{"key":"10.1016\/j.intimp.2024.112184_b0205","doi-asserted-by":"crossref","DOI":"10.1186\/s40537-023-00844-y","article-title":"BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors","volume":"10","author":"Liu","year":"2023","journal-title":"J. Big Data"},{"key":"10.1016\/j.intimp.2024.112184_b0210","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112184_b0215","doi-asserted-by":"crossref","unstructured":"G.K. Smyth, Linear models and empirical bayes methods for assessing differential expression in microarray experiments, Stat. Appl. Genet. Mol. Biol. 3 (2004) 3.","DOI":"10.2202\/1544-6115.1027"},{"key":"10.1016\/j.intimp.2024.112184_b0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112184_b0225","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.intimp.2024.112184_b0230","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1093\/bioinformatics\/btaa1018","article-title":"<i>MOVICS<\/i>: an R package for multi-omics integration and visualization in cancer subtyping","volume":"36","author":"Lu","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.intimp.2024.112184_b0235","article-title":"Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112184_b0240","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.36","article-title":"Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform","volume":"1","author":"Shen","year":"2022","journal-title":"iMeta"},{"key":"10.1016\/j.intimp.2024.112184_b0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using Cell Chat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112184_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101059","article-title":"Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.intimp.2024.112184_b0255","doi-asserted-by":"crossref","DOI":"10.1038\/ni.3836","article-title":"<i>De novo<\/i> induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors","volume":"18","author":"Johansson-Percival","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112184_b0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7150\/jca.50490","article-title":"HnRNP-F promotes the proliferation of bladder cancer cells mediated by PI3K\/AKT\/FOXO1","volume":"12","author":"Li","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2024.112184_b0265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/BLC-170120","article-title":"Tertiary lymphoid structures associate with tumour stage in urothelial bladder cancer","volume":"3","author":"Koti","year":"2017","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.intimp.2024.112184_b0270","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2024.112184_b0275","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2024.112184_b0280","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.intimp.2024.112184_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100671","article-title":"Towards the overcoming of anticancer drug resistance mediated by p53 mutations","volume":"49","author":"Cao","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.intimp.2024.112184_b0290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2024.112184_b0295","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2024.112184_b0300","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4161\/cbt.27328","article-title":"Alterations of high endothelial venules in primary and metastatic tumors are correlated with lymph node metastasis of oral and pharyngeal carcinoma","volume":"15","author":"Shen","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.intimp.2024.112184_b0305","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2024.112184_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100770","article-title":"Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function","volume":"57","author":"Gao","year":"2021","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.intimp.2024.112184_b0315","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.biochem.74.082803.133354","volume":"74","author":"Jeon","year":"2005","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.intimp.2024.112184_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116871","article-title":"Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p\/PTN axis","volume":"239","author":"Yao","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2024.112184_b0325","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5009\/gnl210195","article-title":"circ-LDLRAD3 knockdown reduces cisplatin chemoresistance and inhibits the development of gastric cancer with cisplatin resistance through miR-588 enrichment-mediated SOX5 inhibition","volume":"17","author":"Liang","year":"2023","journal-title":"Gut and Liver"},{"key":"10.1016\/j.intimp.2024.112184_b0330","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2024.112184_b0335","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.coi.2010.03.007","article-title":"Role of PD-1 in regulating acute infections","volume":"22","author":"Brown","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2024.112184_b0340","doi-asserted-by":"crossref","unstructured":"Y. Iwai et al., Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade, Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12293\u201312297, doi: 10.1073\/pnas.192461099.","DOI":"10.1073\/pnas.192461099"},{"key":"10.1016\/j.intimp.2024.112184_b0345","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112184_b0350","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2024.112184_b0355","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2024.112184_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100907","article-title":"Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1\/PD-L1 blockade","volume":"66","author":"Pang","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.intimp.2024.112184_b0365","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drup.2019.04.001","article-title":"YY1 regulates cancer cell immune resistance by modulating PD-L1 expression","volume":"43","author":"Hays","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.intimp.2024.112184_b0370","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112184_b0375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupret","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.intimp.2024.112184_b0380","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001","volume":"30","author":"Hamid","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2024.112184_b0385","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.19.00934","article-title":"Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001","volume":"37","author":"Garon","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2024.112184_b0390","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1016\/j.apsb.2022.07.012","article-title":"Improving cancer immunotherapy<i> via<\/i> co-delivering checkpoint blockade and thrombospondin-1 downregulator","volume":"13","author":"Xiao","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2024.112184_b0395","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention","volume":"20","author":"Cambier","year":"2023","journal-title":"Cell. Mol. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924007021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924007021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:39:12Z","timestamp":1791301152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924007021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":79,"alternative-id":["S1567576924007021"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112184","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated analysis of multiple transcriptomic approaches and machine learning integration algorithms reveals high endothelial venules as a prognostic immune-related biomarker in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112184"}}